Active Surveillance Prostate Cancer Video Chat, November 12th, 2025
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
AnCan – rick
If you have any technical problems, call GoTo at 877 582 7011
AnCan – rick
Dr. Jonathan Epstein – https://advanceduropathology.com Tel: 516-760-2037 jepstein@imppllc.com
AnCan – rick
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881
Bill (VA)
You can be a “6” but that assumes it is all found.
AnCan – rick
Dr. Kristen Scarpato Vanderbilt https://www.vumc.org/urology/person/kristen-scarpato-md-mph
Dan Gifford, Pensacola, FL
Tapping out for the night. See you next week.
AnCan – rick
My bet is that Carroll would not recommend annual Bx for 3+3.
Phil-Toronto
agreed it has to be due pattern4
AnCan – rick
Absolutely agree with Michael